Rubius Therapeutics, Inc. - stock earnings
Stock symbol RUBY is outdated, potentially delisted? Maybe it is available on other exchange?
RUBY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -20.1 million USD | ? USD |
| 2022Q3 | -62.9 million USD | ? USD |
| 2022Q2 | -44.2 million USD | ? USD |
| 2022Q1 | -52.4 million USD | ? USD |
| 2021Q4 | -55.0 million USD | ? USD |
| 2021Q3 | -49.0 million USD | ? USD |
| 2021Q2 | -50.2 million USD | ? USD |
| 2021Q1 | -42.3 million USD | ? USD |
| 2020Q4 | -40.5 million USD | ? USD |
| 2020Q3 | -40.9 million USD | ? USD |
| 2020Q2 | -37.9 million USD | ? USD |
RUBY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -179.7 million USD | ? USD |
| 2021 | -196.5 million USD | ? USD |
| 2020 | -167.7 million USD | ? USD |
| 2019 | -163.5 million USD | ? USD |
| 2018 | -89.2 million USD | ? USD |
| 2017 | -43.8 million USD | ? USD |
RUBY
Price: $0.06
52 week price:
Earnings Per Share: -0.98 USD
P/E Ratio: -2.31
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 513500
Market Capitalization: 1.7 million